Literature DB >> 22814321

MSH6 mutation in a family affected by Muir-Torre syndrome.

Denisa Kacerovska1, Katerina Cerna, Petr Martinek, Petr Grossmann, Michal Michal, Jan Ricar, Dmitry V Kazakov.   

Abstract

Muir-Torre syndrome (MTS), a phenotypic variant of the more common hereditary nonpolyposis colorectal cancer syndrome, or Lynch syndrome, is an autosomal dominantly inherited condition that combines at least one cutaneous sebaceous neoplasm and at least one visceral malignancy. Most patients (~90%) with MTS carry mutations in the MSH2 gene; less than 10% of the cases are associated with a mutation MLH1 gene, and only 3 MTS patients with a pathogenic MSH6 mutation have been previously documented. We report a family affected with MTS in which 3 members (father and 2 sons) were found to harbor a missense mutation c.2633T>C (p.V878A) in exon 4 of the MSH6 gene.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814321     DOI: 10.1097/DAD.0b013e3182446fe2

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  6 in total

Review 1.  An Overview of Autosomal Dominant Tumour Syndromes with Prominent Features in the Oral and Maxillofacial Region.

Authors:  Robert A Kennedy; Selvam Thavaraj; Salvador Diaz-Cano
Journal:  Head Neck Pathol       Date:  2017-01-21

2.  [Sebaceous gland tumor with a rare gene mutation within a tumor syndrome: Muir-Torre syndrome].

Authors:  E Voigt; F Sommer; K D Geiger; L E Pillunat
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

3.  General aspects of colorectal cancer.

Authors:  Josep J Centelles
Journal:  ISRN Oncol       Date:  2012-11-14

4.  Muir-Torre syndrome in a haemodialysis patient.

Authors:  Evonne D Godfrey; Robert A Coward; Deepa Gharpuray-Pandit; Fiona Lalloo; Stuart McKirdy; Alexander Woywodt
Journal:  Clin Kidney J       Date:  2013-08

5.  Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations.

Authors:  Stephanie Jean; Jiaqi Li; Dionyssios Katsaros; Bradley Wubbenhorst; Kara N Maxwell; Lauren Fishbein; Michael W McLane; Chiara Benedetto; Emilie Marion Canuto; Nandita Mitra; Lin Zhang; Katherine L Nathanson; Janos L Tanyi
Journal:  Oncotarget       Date:  2016-07-26

6.  Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome.

Authors:  Dario Simic; Reinhard Dummer; Sandra N Freiberger; Egle Ramelyte; Marjam-Jeanette Barysch
Journal:  Genes (Basel)       Date:  2021-05-20       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.